abstract |
The present invention relates to bispecific constructs that specifically bind to immune-driven cells and, at the same time, IL23R-transfected target cells, and nucleic acids, vectors, host cells, pharmaceutical compositions thereof and dual- Or autoimmune diseases and / or cancers. |